India’s first homegrown mRNA COVID vaccine is currently under final clinical trials: Dr VK Paul

In a Press Conference, Niti Aayog member Dr VK Paul on February 10 said that India’s first homegrown Messenger RNA COVID-19 vaccine is currently under final clinical trials. “India’s first homegrown Messenger RNA (mRNA) COVID-19 vaccine being developed by Pune-based Gennova Biopharmaceuticals is currently under final clinical trials and we hope that we'll be able to use it someday,” said Dr VK Paul.